In patients with relapsing polymyalgia rheumatica, sarilumab with a rapid glucocorticoid taper regimen of 14 weeks led to greater improvements in patient-reported outcomes of health-related quality of ...

More than half of patients with polymyalgia rheumatica have a relapse during tapering of glucocorticoid therapy. Previous studies have suggested that interleukin-6 blockade may be clinically useful in ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved sarilumab for the treatment of polymyalgia rheumatica in adults who have experienced an ...

Clinicians may have an ambivalent attitude about polymyalgia rheumatica, a disabling disease marked by severe muscle pain and stiffness. On the one hand, it is most rewarding to be able to almost ...

Dear Doctor: I am a 77-year-old man who used to exercise regularly. I was diagnosed with polymyalgia rheumatica a couple of years ago. Sometimes I feel like it is going to disappear, and other times ...

Please provide your email address to receive an email when new articles are posted on . “Giant cell arteritis is a heterogeneous disorder with a variety of recognized clinical presentations,” Robert ...

Polymyalgia rheumatica (PMR) is an inflammatory disease, mostly seen in older adults, that causes pain and stiffness in certain areas of the body — often in the neck, shoulders, or hip area. These ...

However, patient-reported scores were not significantly better in the tocilizumab group. Tocilizumab (Actemra) appears to lead to meaningful results in patients with active polymyalgia rheumatica ...